Search

everythinglearnresearchcommunity

for

Search:↓

Boosting certain cell signals can prevent hair loss from chemotherapy and radiation.

Iron deficiency causes hair loss by affecting hair differentiation and cycling.

Homeopathic treatment may help manage alopecia areata by considering the whole person.

BST2 is highly expressed in certain immune cells in alopecia areata, suggesting a role in the disease.

Methylprednisolone pulse therapy works best for recent and specific types of severe alopecia areata.

A heterozygous mutation in HTRA1 can cause severe CARASIL symptoms.

New imaging technology can show up to 40 different markers in hair loss tissue, helping to understand hair disease better.

Technique effectively reconstructs large scalp defects with minimal hair loss and visible scarring.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Rat hair-follicle stem cells can become heart cells with specific supplements.

A mutation in the KRT86 gene causes hair fragility in a Turkish family.

Skin cells and immune cells change in a skin condition called hidradenitis suppurativa, and a certain treatment can improve these changes.

Anti-PD-L1 immunotherapy can cause hair loss and unexpected hair color change, but treatment can restore hair growth and color.

CD8+ T cells drive alopecia areata, while regulatory T cells are protective.

HAT-MSCs can effectively engulf harmful microbes and particles, aiding infection treatment.

The method successfully isolates hair follicle stem cells and skin cells from mice for research.

The scaffold helps wounds heal without scars and promotes hair growth.

Skin and nail changes are common in patients with blood cancers undergoing chemotherapy, affecting their quality of life.

Alopecia areata is linked to blood cancers, especially in older patients, but not to most solid cancers.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

A specific type of immune cell plays a key role in causing alopecia areata and could be a target for treatment.

Researchers created a cell line from a hair follicle to study hair loss.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

Rapamycin increased survival in mice with severe chronic graft-versus-host disease by expanding regulatory T cells.

FTY720 helps transplanted fat survive better by reducing immune rejection and improving blood vessel growth.

Most patients treated with trastuzumab and paclitaxel experience some hair loss, but it's usually not severe.

A 19-year-old with MRKHS developed complete hair loss, and treatment options were discussed.

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.

Hair regrowth improved, but quality of life did not.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.